Patents in Therapeutic Recombinant Protein Production Using Mammalian Cells

Author(s): Virginia Picanco-Castro, Marcela Cristina Correa de Freitas, Aline de Sousa Bomfim, Elisa Maria de Sousa Russo.

Journal Name: Recent Patents on Biotechnology

Volume 8 , Issue 2 , 2014

Become EABM
Become Reviewer


The industrial production of recombinant proteins preferentially requires the generation of stable cell lines expressing proteins in a quick, relatively facile, and a reproducible manner. Different methods are used to insert exogenous DNA into the host cell, and choosing the appropriate producing cell is of paramount importance for the efficient production and quality of the recombinant protein. This review addresses the advances in recombinant protein production in mammalian cell lines, according to key patents from the last 30 years.

Keywords: Mammalian expression system, patents in biopharmaceuticals, recombinant protein.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2014
Page: [165 - 171]
Pages: 7
DOI: 10.2174/1872208309666140904120404

Article Metrics

PDF: 81